Corlanor — Medical Mutual

Initial criteria

• Patient has a left ventricular ejection fraction (LVEF) < 35% at baseline
• Patient is in normal sinus rhythm with a resting heart rate > 70 bpm at baseline
• Patient has tried or is currently receiving one beta-blocker at the maximally tolerated dose for heart failure treatment (e.g., metoprolol succinate sustained-release, carvedilol, bisoprolol, Coreg CR) OR patient has a documented contraindication to use of beta-blocker therapy (e.g., bronchospastic disease such as COPD or asthma, severe hypotension, bradycardia)
• Patient age ≥ 18 years
• Medication is prescribed by or in consultation with a cardiologist

Reauthorization criteria

• Response to therapy is required for continuation

Approval duration

6 months initial, 1 year reauth